In this clip from our 2022 mid-year update conference, Mark Moyad, MD, MPH, asks Matthew Cooperberg, MD, MPH, about how men with a family history of prostate cancer should approach screening. Dr. Cooperberg argues that when there is a strong history of prostate cancer—for example, if multiple family members have been diagnosed or died prematurely from prostate cancer—then 40 would be a reasonable age to begin screening instead of 45, which is the standard recommendation.
To see Dr. Cooperberg's faculty page, visit: [ Ссылка ]
To watch Dr. Cooperberg's full lecture and Q&A and the rest of the first day of our conference, which also featured Eugene Kwon, MD, on "Prostate Cancer Treatments and Imaging" and Jeffrey Brady, MD, on "Treatments for Incontinence," go to: [ Ссылка ]
To View Day 2, featuring Amar Kishan, MD on "Side Effects of Radiation Therapy," Nicholas J. Vogelzang, MD on "Advanced Treatment & Side Effects," and a conference wrap-up with Mark Scholz, MD, and Mark Moyad, MD, MPH, visit: [ Ссылка ]
Don't know your stage? Take the quiz: Visit [ Ссылка ]
To learn more about prostate cancer, visit [ Ссылка ]
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: [ Ссылка ]
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.
